BBIXF 0.05 Bonus BioGroup Ltd.
| Range: | 3.0E-4-0.055 | Vol Avg: | 67 | Last Div: | 0 | Changes: | -0.03 |
| Beta: | 1.02 | Cap: | 0.03B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Jul 30 2019 | Empoloyees: | 58 | ||
| CUSIP: | CIK: | ISIN: | IL0004850116 | Country: | IL | ||
| CEO: | Dr. Shai Meretzki Ph.D. | Website: | https://www.bonusbiogroup.com | ||||
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow